Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusion in rats.
Tomita, H
Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusion in rats. [electronic resource] - Pancreas Sep 1994 - 638-45 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0885-3177
10.1097/00006676-199409000-00015 doi
Animals
Body Weight--drug effects
Cholecystokinin--genetics
Duodenum--drug effects
Eating--drug effects
Intestinal Mucosa--drug effects
Ligation
Male
Organ Size--drug effects
Pancreatic Ducts--surgery
Pancreatitis--drug therapy
Proglumide--analogs & derivatives
Proteins--metabolism
Rats
Rats, Wistar
Receptors, Cholecystokinin--antagonists & inhibitors
Regeneration--physiology
Lack of effect of cholecystokinin receptor antagonist (CR1505) on recovery of experimental pancreatitis after pancreatic duct occlusion in rats. [electronic resource] - Pancreas Sep 1994 - 638-45 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0885-3177
10.1097/00006676-199409000-00015 doi
Animals
Body Weight--drug effects
Cholecystokinin--genetics
Duodenum--drug effects
Eating--drug effects
Intestinal Mucosa--drug effects
Ligation
Male
Organ Size--drug effects
Pancreatic Ducts--surgery
Pancreatitis--drug therapy
Proglumide--analogs & derivatives
Proteins--metabolism
Rats
Rats, Wistar
Receptors, Cholecystokinin--antagonists & inhibitors
Regeneration--physiology